Global Pharmaceutical Analytical Testing Outsourcing Market to Reach $14.6 Billion by 2030
The global market for Pharmaceutical Analytical Testing Outsourcing estimated at US$8.1 Billion in the year 2022, is projected to reach a revised size of US$14.6 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2022-2030. Bioanalytical Testing, one of the segments analyzed in the report, is projected to record 9.1% CAGR and reach US$5.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Method Development & Validation segment is readjusted to a revised 7.5% CAGR for the next 8-year period.The U.S. Market is Estimated at $2.4 Billion, While China is Forecast to Grow at 6.9% CAGR
The Pharmaceutical Analytical Testing Outsourcing market in the U.S. is estimated at US$2.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 6.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 5.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.Select Competitors (Total 42 Featured) -
- Bioreliance
- Boston Analytical
- Charles River Laboratories International, Inc.
- Dalton Pharma Services
- Eurofins Scientific
- Exova
- Halo Pharma
- Intertek Group PLC
- Pace Analytical Services, LLC
- Pharmaceutical Product Development, LLC
- SGS SA
- Toxikon, Inc.
- West Pharmaceutical Services, Inc.
- WuXi AppTec, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bioreliance
- Boston Analytical
- Charles River Laboratories International, Inc.
- Dalton Pharma Services
- Eurofins Scientific
- Exova
- Halo Pharma
- Intertek Group PLC
- Pace Analytical Services, LLC
- Pharmaceutical Product Development, LLC
- SGS SA
- Toxikon, Inc.
- West Pharmaceutical Services, Inc.
- WuXi AppTec, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 93 |
Published | May 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 8.1 Billion |
Forecasted Market Value ( USD | $ 14.6 Billion |
Compound Annual Growth Rate | 7.6% |
Regions Covered | Global |